Table 1 Characteristics of patients with histopathologically diagnosed T1 HG bladder cancers
Groups parameter | Total (n = 145) | With Ins | Without Ins | p value | ||
|---|---|---|---|---|---|---|
(1) | (2) | (3) | ||||
G2 (n = 6) | G3 (n = 70) | G2 (n = 32) | G3 (n = 37) | |||
Sex, n (%) | ||||||
Male | 117 (81) | 6 (100) | 57 (81) | 27 (84) | 27 (73) | |
Female | 28 (19) | 0 (0) | 13 (19) | 5 (16) | 10 (27) | 0.4105 |
Age | ||||||
Median (min–max) (yr) | 74 (32–89) | 75 (56–86) | 73 (47–89) | 74 (57–87) | 76 (32–88) | 0.5777 |
< 70, n (%) | 54 (37) | 2 (33) | 27 (39) | 9 (28) | 16 (43) | |
≧ 70, n (%) | 91 (63) | 4 (67) | 43 (61) | 23 (72) | 21 (57) | 0.4230 |
Number of tumors, n (%) | ||||||
Single | 52 (36) | 2 (33) | 22 (31) | 14 (44) | 14 (38) | |
Multiple | 93 (64) | 4 (67) | 48 (69) | 18 (56) | 23 (62) | 0.4639 |
Maximum diameter, n (%) | ||||||
< 3 cm | 116 (80) | 5 (83) | 54 (77) | 27 (84) | 30 (81) | |
≧ 3 cm | 29 (20) | 1 (17) | 16 (23) | 5 (16) | 7 (19) | 0.7623 |
History of recurrence, n (%) | ||||||
Primary | 103 (71) | 3 (50) | 54 (77) | 17 (53) | 29 (78) | |
Recurrent | 42 (29) | 3 (50) | 16 (23) | 15 (47) | 8 (22) | 0.0492 |
Concomitant CIS, n (%) | ||||||
No | 111 (77) | 5 (83) | 43 (61) | 31 (97) | 32 (86) | |
Yes | 34 (23) | 1 (17) | 27 (39) | 1 (3) | 5 (14) | 0.0001 |
WHO grade 1973, n (%) | ||||||
G2 | 38 (26) | 6 (100) | 0 (0) | 32 (100) | 0 (0) | |
G3 | 107 (74) | 0 (0) | 70 (100) | 0 (0) | 37 (100) | < 0.0001 |
Second TURBT, n (%) | ||||||
No | 46 (32) | 2 (33) | 10 (14) | 24 (75) | 10 (27) | |
Yes | 99 (68) | 4 (67) | 60 (86) | 8 (25) | 27 (73) | < 0.0001 |
Ins in a series, n (%) | ||||||
No | 69 (48) | 0 (0) | 0 (0) | 32 (100) | 37 (100) | |
Yes | 76 (52) | 6 (100) | 70 (100) | 0 (0) | 0 (0) | < 0.0001 |
Ins in whole lifetime, n (%) | ||||||
No | 60 (41) | 0 (0) | 0 (0) | 29 (91) | 31 (84) | |
Yes | 85 (59) | 6 (100) | 70 (100) | 3 (9) | 6 (16) | < 0.0001 |